LEXX Lexaria: Accounting Book Value Bawat Bahagi

Grapikong logo ng Lexaria Bioscience Corp. (LEXX)

Layunin ng Lexaria Bioscience (LEXX) na monetisa ang DehydraTECH sa pamamagitan ng licensing upang pabilisin ang drug absorption. Ang average book value bawat share ay nagpapakita ng pag-unlad tungo sa layuning ito, kung saan ang halaga ay nag-stabilize sa 2.84. Gayunpaman, ang paglago ay nalilimitahan ng pagdepende sa mga scientific breakthrough na nangyayari sa labas ng mga market cycle at ang unti-unting pagkaubos ng mga reserba dahil sa mga gastos sa clinical trial sa kawalan ng regular na kita.

Lexaria (LEXX): Book Value ng Bahagi mula 04.07.2022 hanggang 27.10.2026
Mga produktong ginagawa ng Lexaria

Ang Lexaria Bioscience (LEXX) ay bumubuo ng makabagong DehydraTECH system upang i-optimize ang bioavailability ng gamot at bawasan ang toxicity. Sa pamamagitan ng pagsusuri sa dynamics ng book value per share, tinataya ng isang investor ang residual equity ng kumpanya minus lahat ng liabilities, na siyang nagtatakda ng tunay na asset backing ng bawat share at nagsisilbing indicator ng financial stability ng negosyo sa panahon ng technological development.

Mga kakumpitensya ng Lexaria Bioscience (LEXX)

Haleon Group (HLN) - Accounting Book Value Bawat Bahagi|Kenvue Health (KVUE) - Stockholders Equity Bawat Bahagi|Accounting Book Value Bawat Bahagi Verona Pharma plc|MENS (jyongbio.com) - Stockholders Equity Bawat Bahagi|Netong Asset Bawat Isang Bahagi Ligand LGND|Book Value ng Bahagi Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value Bawat Bahagi|Accounting Value ng Bahagi Alvotech Biopharmaceuticals (ALVO)|Book Value Bawat Bahagi LQDA (Liquidia Corporation)|glpg.com - Book Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value ng Bahagi|AMPH (Amphastar) - Netong Asset Bawat Isang Bahagi|Pacira Corp (PCRX) - Accounting Book Value Bawat Bahagi|SPRY (ARS Pharmaceuticals) - Book Value Bawat Bahagi|Book Value Bawat Bahagi theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Book Value Bawat Bahagi|Accounting Value ng Bahagi SCPH (scpharmaceuticals.com)|TECX: Netong Asset Bawat Isang Bahagi|TNXP - Net Asset Value Bawat Bahagi|Accounting Book Value Bawat Bahagi SXT China SXTC|EPRX - Book Price ng Bahagi|Book Value Bawat Bahagi BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value ng Bahagi|Book Value Bawat Bahagi ORMP (Oramed)|Net Asset Value Bawat Bahagi ENTX|MindWalk Holdings (HYFT) - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi ABVC (abvcpharma.com)|Netong Asset Bawat Isang Bahagi Cumberland Pharmaceuticals Inc. CPIX|Netong Asset Bawat Isang Bahagi Quantum BioPharma Ltd. QNTM|FGEN (FibroGen Corp) - Book Value Bawat Bahagi|Telomir Pharmaceuticals Corp (TELO) - Net Asset Value Bawat Bahagi|Accounting Book Value Bawat Bahagi ranitherapeutics.com|Synergy CHC (SNYR) - Stockholders Equity Bawat Bahagi|RLYB (Rallybio Corp) - Book Value Bawat Bahagi|Book Value Bawat Bahagi PULM|Pheton Holdings Ltd (PTHL) - Netong Asset Bawat Isang Bahagi|Accounting Value ng Bahagi aptorumgroup.com (APM)|Book Value Bawat Bahagi LYRA|Net Assets Bawat Bahagi Impact BioMedical, Inc. IBO|TNF Pharma - Book Value Bawat Bahagi|cbdMD, Inc. (YCBD) - Book Value Bawat Bahagi|Accounting Book Value Bawat Bahagi PainReform Limited PRFX|Altamira Therapeutics Ltd. (CYTO) - Accounting Value ng Bahagi|Book Value Bawat Bahagi Lipella Pharmaceuticals|Netong Asset Bawat Isang Bahagi optinose.com|PIRS (Pieris Pharmaceuticals, Inc.) - Book Value Bawat Bahagi|Net Assets Bawat Bahagi PROC (Procaps Group)|PTPI: Netong Asset Bawat Isang Bahagi|Qilian International Corp - Net Asset Value Bawat Bahagi|Netong Asset Bawat Isang Bahagi SLRN (Acelyrin, Inc.)|TFFP - Net Assets Bawat Bahagi